InterLynk Partner Metatissue Promotes Human-Sourced Biomaterials at Major Science Events
Metatissue advances human protein-based biomaterials, presenting their innovations at prominent conferences throughout Europe and Asia.
Metatissue, a vital partner in the InterLynk project, is dedicated to designing and manufacturing human protein-based products for cell culture, tissue engineering and regeneration. A defining characteristic of Metatissue’s portfolio is its use of xeno-free, human-derived platelet lysates, which create bioactive environments that support realistic cell culture conditions.
“At Metatissue, we believe that human-sourced biomaterials are essential for advancing research ethically and effectively. Our commitment is to empower scientists with materials that closely mimic human biology, supporting meaningful advancements across different research fields,” says Catarina Custodio, Co-Founder and CEO of Metatissue.
Designed to replicate the complexities of human tissue interactions, Metatissue’s biomaterials allow for more accurate and relevant in vitro studies without the need for animal-derived components, representing a significant ethical and scientific advancement.
Among Metatissue’s products are methacryloyl-modified platelet lysates in various forms, each designed to enhance control over cell culture environments. Their hPLMA/500 and hPLMA/1000 products are photopolymerizable hydrogels, formulated as easy-to-prepare solutions that can be cured with light to form hydrogels with adjustable mechanical properties. The hPLMA/100 offers an enhanced level of control over gelation and stiffness. Two new additions will soon join the lineup: the hPLMA Easy, which will come pre-mixed with a photoinitiator for added convenience, and the hPLMA Sponge, a porous scaffold ready for use without the need for photoinitiation, suitable for cell migration and growth in well-plate applications. Together, these products offer researchers versatile and physiologically relevant platforms for cell culture, uniquely based on human platelet lysates.
In 2024, Metatissue actively promoted these innovations at several key scientific events worldwide, engaging with the scientific community on the future of human-derived biomaterials. Highlights include their participation in the World Biomaterials Congress (WBC) in Daegu, South Korea, as well as prominent European events such as the Curious 2024 – Future Insight Conference in Mainz (Germany), Ciencia 2024 in Porto (Portugal), and the EUROoCS Annual Meeting in Milan (Italy). At the EUSAAT Conference in Linz (Austria), Dr. Sara Santos from Metatissue delivered a noteworthy presentation, “Advanced Allogeneic Porous Scaffolds for Cell Culture and Personalised Xeno-Free Tissue Engineering,” emphasizing the potential of xeno-free biomaterials to reshape research and regenerative applications.
As a partner in InterLynk, Metatissue’s human platelet lysate-based biomaterials are integral to advancing the project’s mission of developing highly biofunctional scaffolds for tissue regeneration. These materials serve as foundational elements in the development of composite inks which will be used to create tailored, multi-material scaffolds to support complex tissue repair. By reducing risks of immune rejection and contamination, Metatissue’s biomaterials align closely with InterLynk’s goal of creating biocompatible solutions that support effective tissue regeneration.
Through its role in InterLynk and active presence at leading events, Metatissue continues to promote the importance of human-sourced biomaterials, supporting the scientific community’s move toward more ethical, accurate, and effective regenerative approaches.
Click here and discover more about Metatissue’s groundbreaking work in human-based biomaterials.
